GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » MicroTech Medical (Hangzhou) Co Ltd (HKSE:02235) » Definitions » LT-Debt-to-Total-Asset

MicroTech Medical (Hangzhou) Co (HKSE:02235) LT-Debt-to-Total-Asset : 0.00 (As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is MicroTech Medical (Hangzhou) Co LT-Debt-to-Total-Asset?

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. MicroTech Medical (Hangzhou) Co's long-term debt to total assests ratio for the quarter that ended in Dec. 2023 was 0.00.

MicroTech Medical (Hangzhou) Co's long-term debt to total assets ratio stayed the same from Dec. 2022 (0.00) to Dec. 2023 (0.00).


MicroTech Medical (Hangzhou) Co LT-Debt-to-Total-Asset Historical Data

The historical data trend for MicroTech Medical (Hangzhou) Co's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MicroTech Medical (Hangzhou) Co LT-Debt-to-Total-Asset Chart

MicroTech Medical (Hangzhou) Co Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
LT-Debt-to-Total-Asset
- - - - -

MicroTech Medical (Hangzhou) Co Semi-Annual Data
Dec19 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
LT-Debt-to-Total-Asset Get a 7-Day Free Trial Premium Member Only - - - - -

MicroTech Medical (Hangzhou) Co LT-Debt-to-Total-Asset Calculation

MicroTech Medical (Hangzhou) Co's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Dec. 2023 is calculated as

LT Debt to Total Assets (A: Dec. 2023 )=Long-Term Debt & Capital Lease Obligation (A: Dec. 2023 )/Total Assets (A: Dec. 2023 )
=0.182/2361.23
=0.00

MicroTech Medical (Hangzhou) Co's Long-Term Debt to Total Asset Ratio for the quarter that ended in Dec. 2023 is calculated as

LT Debt to Total Assets (Q: Dec. 2023 )=Long-Term Debt & Capital Lease Obligation (Q: Dec. 2023 )/Total Assets (Q: Dec. 2023 )
=0.182/2361.23
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


MicroTech Medical (Hangzhou) Co  (HKSE:02235) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.


MicroTech Medical (Hangzhou) Co LT-Debt-to-Total-Asset Related Terms

Thank you for viewing the detailed overview of MicroTech Medical (Hangzhou) Co's LT-Debt-to-Total-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


MicroTech Medical (Hangzhou) Co Business Description

Traded in Other Exchanges
N/A
Address
No. 108 Liuze Street, Cangqian Street, Yuhang District, Zhejiang Province, Hangzhou, CHN
MicroTech Medical (Hangzhou) Co Ltd is engaged in the research and development and manufacturing and commercialization of diabetes management, providing both diabetes treatment and diabetes monitoring medical devices to improve diabetes management in China and the rest of the world. The company derives a majority of its revenue from China.
Executives
Zheng Pan
Master Summer Limited 2201 Interest of corporation controlled by you
Cdbi Partners Gp, Ltd 2201 Interest of corporation controlled by you
Cdbi Partners Fund Ii, L.p. 2201 Interest of corporation controlled by you
Cdbi Partners Fund I, L.p. 2201 Interest of corporation controlled by you
Cdbi Gp, Ltd 2201 Interest of corporation controlled by you
Cd Capital Healthcare Fund V, L.p. 2201 Interest of corporation controlled by you
Cd Capital Gp Ltd 2201 Interest of corporation controlled by you
Zhe Jiang Jiu Ren Zi Ben Guan Li You Xian Gong Si 2201 Interest of corporation controlled by you
Qiming Corporate Gp V, Ltd. 2201 Interest of corporation controlled by you
Qiming Gp V, L.p. 2201 Interest of corporation controlled by you
Qiming Venture Partners V, L.p. 2201 Interest of corporation controlled by you
Qm32 Limited 2101 Beneficial owner
Lav Asset Management (hong Kong) Limited 2102 Investment manager
Lav Evergreen (hong Kong) Co., Limited 2101 Beneficial owner

MicroTech Medical (Hangzhou) Co Headlines

No Headlines